Zurich Cantonal Bank
SCLN

Zurich Cantonal Bank’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Zurich Cantonal Bank’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,238
Closed -$47K – 2608
2017
Q3 		$47K Hold
4,238
– – ﹤0.01% 1851
2017
Q2 		$47K Hold
4,238
– – ﹤0.01% 1805
2017
Q1 		$42K Hold
4,238
– – ﹤0.01% 1875
2016
Q4 		$46K Hold
4,238
– – ﹤0.01% 1756
2016
Q3 		$43K Hold
4,238
– – ﹤0.01% 1742
2016
Q2 		$55K Hold
4,238
– – ﹤0.01% 1463
2016
Q1 		$47K Hold
4,238
– – ﹤0.01% 1469
2015
Q4 		$39K Buy
4,238
+3,506
+479% +$29.3K ﹤0.01% 1585
2015
Q3 		$5K Buy
+732
New +$6.27K ﹤0.01% 2407

Zurich Cantonal Bank's SCLN Position: Q4 2017 in Review

Zurich Cantonal Bank sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 4,238 shares — an estimated $47K sold.

Zurich Cantonal Bank first reported a position in SCLN in Q3 2015 and held it in 9 quarters. The position peaked at $55K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Zurich Cantonal Bank reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Zurich Cantonal Bank sold 4,238 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $47K.
  • Zurich Cantonal Bank first reported a position in Sciclone Pharmaceuticals Inc in Q3 2015 and held it in 9 quarters.
  • Zurich Cantonal Bank's Sciclone Pharmaceuticals Inc position peaked at $55K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Zurich Cantonal Bank's 13F filing for Q4 2017, filed 31 Jan 2018.